))
Tirzepatide Weight Loss in Chaos
Manage episode 459986154 series 3563192
Content provided by Katherine Dee and Dr. Kate Dee. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Katherine Dee and Dr. Kate Dee or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode of MedSpa Mayhem, Dr. Kate Dee discusses the turmoil surrounding the weight loss drugs semaglutide and tirzepatide, focusing on recent FDA regulations and the ongoing legal battles involving compounding pharmacies. Dr. Dee explains the benefits and side effects of these drugs, particularly the differences between semaglutide and tirzepatide, and shares her personal and professional experiences with them. The episode also covers the impact of FDA decisions on med spas across the country, potential shifts in drug availability, and the ethical and legal dilemmas faced by practitioners. Furthermore, Dr. Dee provides an update on Dr. Sagan’s ongoing lawsuit with Eli Lilly for false advertising and trademark infringement.
Takeaways:
- Tirzepatide has been declared no longer in shortage by the FDA
- Compounding pharmacies have limited time to sell what they have on hand
- The GLP-1 Weight Loss industry is in chaos, and the drugs will likely be in very short supply and costs are likely to rise
Email Dr. Kate Dee at [email protected]
Check out the Medspa Mayhem website for
More about Dr. Dee
Upcoming appearances
Links to buy the book on Bookshop, B&N, Amazon
Press and Podcast info
Glow Medispa in Seattle, WA
Purchase Medspa Mayhem on Amazon
Chapters
01:10 The Tirzepatide Saga
02:37 Compounding Pharmacies and Legal Issues
06:22 FDA Announcements and Lawsuits
11:05 Personal Experiences and Future Predictions
15:22 Updates on Dr. Sagan and Conclusion
55 episodes
Share
